Alzheimer's Disease Essay

1430 Words6 Pages
Alzheimer's Disease 1 ALZHEIMER'S DISEASE Name: Course: Tutor’s Name: (16 September 2011) Alzheimer's Disease 2 Introduction Alzheimer's disease was named after German psychiatrist Alois Alzheimer who described it in 1906. It is a progressive, incurable, degenerative, and terminal neurologic disease of the brain leading to the irreversible loss of neurons and the loss of intellectual abilities, including memory and reasoning. These changes become severe enough to impede social or occupational functioning. The disease is also known as simply Alzheimer's, and Senile Dementia of the Alzheimer Type (SDAT). Causes Plaques and tangles in the brain have been indicated using extensive autopsy studies. The plaques are accumulated β-amyloid…show more content…
These are based on the presence of characteristic neurological and neuropsychological features and the absence of alternative conditions. To exclude other cerebral pathology or subtypes of dementia, advanced medical imaging with computed tomography (CT) or magnetic resonance imaging (MRI), and with single photon emission computed tomography (SPECT) or positron emission tomography (PET) can be used. This diagnosis may predict conversion from prodromal stages (mild cognitive impairment) to Alzheimer's disease. Thus an assessment of intellectual functioning including memory testing can further characterize the state of the disease. Medical organizations have created diagnostic criteria to ease and standardize the diagnostic process for practicing physicians. The only way that highly accurate diagnosis can be confirmed is by a postmortem when brain material is available and can be examined histologically. Treatment Alzheimer's disease is not treatable. It can only be prevented and to those who have the disease care giving is necessary. Prevention involves Though various approaches, including those that nourish and exercise the brain, are suggested, none of them have been scientifically proven. It has been suggested that a Alzheimer's disease onset can be delayed or stopped by long term use of…show more content…
"Quantifying age-related myelin breakdown with MRI: novel therapeutic targets for preventing cognitive decline and Alzheimer's disease". Journal of Alzheimer's disease: JAD 6 (6 Supplement), S53–9. Games D, Adams D, Alessandrini R, et al. (1995). Alzheimer-type neuropathology in transgenic mice over expressing V717F beta-amyloid precursor protein. Nature 373(6514), pp. 523–27. Hsiao K, Chapman P, Nilsen S, et al. (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (5284), pp. 99–102. Lalonde R, Dumont M, Staufenbiel M, Sturchler-Pierrat C, Strazielle C. (2002). Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation. Brain Research 956 (1), pp. 36–44. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D (1996). Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J Neuroscience 16 (18), pp.

More about Alzheimer's Disease Essay

Open Document